Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Zealand Pharma A/S ZEAL
$17.59
На 18:00, 12 мая 2023
+81.92%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
32.12
-
week52low
9.93
-
Revenue
292567000
-
P/E TTM
-4
-
Beta
1.33627000
-
EPS
0.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 ноя 2022 г. в 01:11
Описание компании
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin and Lyxumia; Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia, congenital hyperinsulinism, and post bariatric surgery hypoglycemia; and Dasiglucagon dual-hormone artificial pancreas for automated diabetes management. The company's pipeline includes Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion Pharmaceuticals, Inc.; and Beta Bionics, Inc. The company was incorporated in 1998 and is headquartered in Copenhagen, Denmark.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Needham | Buy | Buy | 13 мая 2022 г. |
| Morgan Stanley | Overweight | Overweight | 13 ноя 2020 г. |
| Morgan Stanley | Overweight | Overweight | 13 окт 2020 г. |
| Morgan Stanley | Overweight | Overweight | 14 авг 2020 г. |
| Morgan Stanley | Overweight | Overweight | 15 июл 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results
GlobeNewsWire
04 мая 2023 г. в 11:05
Press Release– No. 3 / 2023 Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results Copenhagen, Denmark, May 4, 2023 – a Zealand Pharma A/S (CVR-no.
Zealand Pharma A/S (ZEAL) Q4 2022 Earnings Call Transcript
Seeking Alpha
02 мар 2023 г. в 12:55
Zealand Pharma A/S (ZEAL) Q4 2022 Results Conference Call March 1, 2022 8:00 AM ET Company Participants Anna Krassowska - VP, IR Adam Steensberg - President, CEO Henriette Wennicke - CFO David Kendall - CMO Conference Call Participants Thomas Bowers - Danske Bank Brian Balchin - Jefferies Michael Novod - Nordea Jesper Ilsoe - Carnegie Mark Purcell - Morgan Stanley Operator Good day, and thank you for standing by. Welcome to the Zealand Pharma Results for the Full Year 2022 Conference Call.
Zealand Pharma to Host Conference Call on March 2, 2023 at 2 pm CET (8 am ET) to Present Full Year Results for 2022
GlobeNewsWire
24 февр 2023 г. в 01:00
Press release – No. 1 / 2023
Zealand Pharma A/S (ZEAL) Q3 2022 Earnings Call Transcript
Seeking Alpha
11 ноя 2022 г. в 16:42
Zealand Pharma A/S (ZEAL) Q3 2022 Earnings Conference Call November 10, 2022 10:00 AM ET Company Participants Anna Krassowska - Vice President, Investor Relations & Corporate Communications Adam Steensberg - President & Chief Executive Officer Henriette Wennicke - Chief Financial Officer David Kendall - Chief Medical Officer Conference Call Participants Joseph Stringer - Needham & Company Brian Balchin - Jefferies Operator Good day and thank you for standing by. Welcome to Zealand Pharma Results for Third Quarter 2022 Conference Call.
Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022
GlobeNewsWire
03 ноя 2022 г. в 04:00
Company announcement – No. 49 / 2022